Spire Wealth Management Novartis Ag Transaction History

Spire Wealth Management

$3.01 Billion
Q1 2024

A detailed history of Spire Wealth Management transactions in Novartis Ag stock. As of the latest transaction made, Spire Wealth Management holds 3,584 shares of NVS stock, worth $381,480. This represents 0.01% of its overall portfolio holdings.

Number of Shares

3,584

Previous 3,757 4.6%

Holding current value

$381,480

Previous $379,000 8.71%

% of portfolio

0.01%

Previous 0.01%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 24, 2024	SELL	$95.27 - $108.47 $16,481 - $18,765	-173 Reduced 4.6%	3,584 $346,000
Q4 2023 Feb 06, 2024	SELL	$92.27 - $101.54 $1,384 - $1,523	-15 Reduced 0.4%	3,757 $379,000
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $25,766 - $28,595	272 Added 7.77%	3,772 $384,000
Q2 2023 Aug 09, 2023	SELL	$92.52 - $104.91 $52,643 - $59,693	-569 Reduced 13.98%	3,500 $353,000
Q1 2023 May 09, 2023	BUY	$80.03 - $92.81 $74,107 - $85,942	926 Added 29.46%	4,069 $374,000

Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $15,865 - $19,429	210 Added 7.16%	3,143 $285,000
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $131,761 - $154,101	-1,766 Reduced 37.58%	2,933 $223,000
Q2 2022 Jul 22, 2022	SELL	$80.52 - $93.75 $227,066 - $264,375	-2,820 Reduced 37.5%	4,699 $397,000
Q1 2022 Apr 18, 2022	SELL	$80.11 - $90.62 $259,155 - $293,155	-3,235 Reduced 30.08%	7,519 $660,000
Q4 2021 Jan 14, 2022	BUY	$79.7 - $88.13 $413,324 - $457,042	5,186 Added 93.14%	10,754 $941,000
Q3 2021 Oct 22, 2021	BUY	$81.78 - $95.14 $8,178 - $9,514	100 Added 1.83%	5,568 $455,000
Q2 2021 Jul 26, 2021	SELL	$85.24 - $94.15 $290,838 - $321,239	-3,412 Reduced 38.42%	5,468 $499,000
Q1 2021 May 21, 2021	BUY	$83.5 - $98.47 $741,480 - $874,413	8,880 New	8,880 $766,000

Others Institutions Holding NVS

# of Institutions

1,346

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $229B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Spire Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Spire Wealth Management with notifications on news.

Account

Spire Wealth Management Novartis Ag Transaction History